Invention Grant
![Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors](/docs/US/2022-10-18/US11472802B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors
-
Application No.: US16962305Application Date: 2019-01-18
-
Publication No.: US11472802B2Publication Date: 2022-10-18
- Inventor: Shane M. Walls , Li Ren , Ginelle A. Ramann , David A. Moreno , Andrew T. Metcalf , Elizabeth A. McFaddin , Gabrielle R. Kolakowski , James F. Blake , Donghua Dai , Julia Haas , Yutong Jiang , Dean Kahn
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Meunier Carlin & Curfman LLC
- International Application: PCT/US2019/014277 WO 20190118
- International Announcement: WO2019/143994 WO 20190725
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00 ; C07F9/6561
![Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors](/abs-image/US/2022/10/18/US11472802B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are compounds of the Formula I: and tautomers and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2 and R3 have the meanings given in the specification, which are inhibitors of RET kinase and are useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders.
Public/Granted literature
- US20200339579A1 SUBSTITUTED PYRAZOLYL[4,3-C]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS Public/Granted day:2020-10-29
Information query
